A Quest of Great Importance-Developing a Broad Spectrum Escherichia coli Phage Collection

Joanna Kaczorowska1, Eoghan Casey2, Horst Neve3

  • 1School of Microbiology and APC Microbiome Ireland, University College Cork, Western Road, T12 YT20 Cork, Ireland. j.m.kaczorowska@amc.uva.nl.

Viruses
|September 29, 2019
PubMed

Insights

Bacteriophages (phages) show promise for treating diarrheal diseases caused by Shigella and E. coli in children. This study isolated phages effective against various E. coli strains and some Shigella sonnei.

Area of Science:

  • Microbiology
  • Virology
  • Infectious Diseases

Background:

  • Antibiotic resistance is a growing problem for treating diarrheal diseases in children.
  • Enterotoxigenic Escherichia coli (E. coli) and Shigella species are common causes of diarrhea in developing countries.
  • Bacteriophages (phages) offer an alternative to antibiotics for bacterial infections.

Purpose of the Study:

  • To isolate and characterize bacteriophages capable of infecting E. coli and Shigella species.
  • To evaluate the host range and genetic diversity of isolated phages.
  • To explore phage therapy as an alternative to antibiotics for pediatric diarrheal diseases.

Main Methods:

  • Screening of environmental and industrial water samples for phages.
  • Isolation and testing of 19 phages against E. coli (ECOR collection, O157:H7) and Shigella sonnei strains.
  • Genome sequencing and morphological characterization of 10 selected phages.

Main Results:

  • Nineteen phages were isolated, with 10 selected for further analysis based on distinct host ranges.
  • The selected phages infected 61 out of 72 E. coli strains in the ECOR collection.
  • Genome analysis revealed five known genetic subgroups and one new subgroup among the isolated phages.

Conclusions:

  • Isolated bacteriophages demonstrate broad host ranges against E. coli and potential for Shigella infection.
  • Phage therapy is a viable alternative to antibiotics for combating pediatric diarrheal diseases.
  • Further research into phage genomics and efficacy is warranted.